MedPath

Droperidol OR Midazolam (DORM) for sedation in patients with psychostimulant induced agitatio

Not Applicable
Completed
Conditions
Psychostimulant induced agitation and delirium
Injuries and Accidents - Poisoning
Registration Number
ACTRN12607000527460
Lead Sponsor
Geoffrey Isbister
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
120
Inclusion Criteria

Emergency department patients with suspected or confirmed severe agitated delirium/psychosis or aggression due to psychostimulant toxicity; AND require intervention by hospital security staff or physical restraint

Exclusion Criteria

1.Patients with acute psychosis clearly due to other causes;
2.Patient who are willing to take oral or intravenous medication for sedation without physical restraint;
3.Patients under the age of 18 years of age;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time until all clear by the security staff [ie. patient is safely restrained and sedated] to estimate onset of sedation[Outcome is a measure of time which commences at the time of intramuscular administration of treatment or comparator drugs];Time until the next dose of parenteral medication for sedation to estimate duration of sedation[Outcome is a measure of time]
Secondary Outcome Measures
NameTimeMethod
Reduction in a 6-point agitation scale (6=highly aroused and violent, 0=asleep)[From baseline to 20 minutes after trial medication];Reduction in the altered mental status scale[From baseline to 20 minutes after trial medication];Injuries to the patient or staff members[During Emergency Department [ED] admission];Requirement for further parenteral sedation[During Emergency Department [ED] admission];Total oral sedation required[During Emergency Department [ED]admission];Further calls for security staff to the patient[During Emergency Department [ED] admission]
© Copyright 2025. All Rights Reserved by MedPath